Shanghai Haohai Biological Technology Co (SHSE:688366) Total Payout Ratio : 0.00 (As of May. 19, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Shanghai Haohai Biological Technology Co's current Total Payout Ratio is 0.00.

Shanghai Haohai Biological Technology Co Total Payout Ratio Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Total Payout Ratio Chart

Shanghai Haohai Biological Technology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Payout Ratio

Get a 7-Day Free Trial

0.68

0.35

1.14

0.52

0.83

Shanghai Haohai Biological Technology Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Shanghai Haohai Biological Technology Co's Total Payout Ratio

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Haohai Biological Technology Co's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Total Payout Ratio falls into.

Save Embed

;

Save Embed

;

Shanghai Haohai Biological Technology Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Shanghai Haohai Biological Technology Co's Total Payout Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-175.354	+	49.451	+	-259.859)	/	466.145
	=	0.83

Shanghai Haohai Biological Technology Co's Total Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	79.558
	=	0.00

Shanghai Haohai Biological Technology Co Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haohai Biological Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

06826:Hong Kong

Address

No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN

Website

https://www.3healthcare.com

Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Executives

Tang Min Jie	Directors, senior managers
Du Peng	Core technical personnel
Hou Yong Tai	Director, core technical staff
Jiang Li Xia	Core technical personnel
	Core technical personnel
Liu Lu	Core technical personnel
Ren Cai Xia	senior management
Wang Wen Bin	Senior management, core technical personnel
Wu Jian Ying	Directors, senior managers
Liu Yuan Zhong	Supervisors
Huang Ming	Director
Zhang Jun Dong	Senior management, core technical personnel
You Jie	Director
Tian Min	senior management
Chen Yi Yi	Director

Shanghai Haohai Biological Technology Co Headlines

No Headlines